Anti-Bcl6 antibody [EP529Y]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(2 Reviews)
|
(9 Publications)
Rabbit Recombinant Monoclonal BCL6 antibody. Suitable for WB, IP and reacts with Human samples. Cited in 9 publications.
View Alternative Names
BCL5, LAZ3, ZBTB27, ZNF51, BCL6, B-cell lymphoma 6 protein, BCL-6, B-cell lymphoma 5 protein, Protein LAZ-3, Zinc finger and BTB domain-containing protein 27, Zinc finger protein 51, BCL-5
- IP
Lab
Immunoprecipitation - Anti-Bcl6 antibody [EP529Y] (AB33901)
Bcl6 was immunoprecipitated from Ramos (human Burkitt's lymphoma B lymphocyte), whole cell lysate with ab33901 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab33901 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution. Lane 1 (Input) : Ramos (human Burkitt's lymphoma B lymphocyte), whole cell lysate, 10 μg Lane 2 (+) : Ramos whole cell lysate Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab33901 in Ramos whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/1000 dilution
Lane 1:
Ramos (human Burkitt's lymphoma B lymphocyte), whole cell lysate at 10 µg
Lane 2:
Ramos whole cell lysate
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Predicted band size: 79 kDa
Observed band size: 78 kDa
false
- WB
Lab
Western blot - Anti-Bcl6 antibody [EP529Y] (AB33901)
Blocking and diluting buffer : 5% NFDM/TBST.
This antibody works better in 1%SDS Hot Lysates in WB. For Lysate preparation protocol, please refer to the protocol section of the website and/or here.
All lanes:
Western blot - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/1000 dilution
Lane 1:
Daudi (Human Burkitt's lymphoma lymphoblast) whole cell lysates prepared in RIPA lysis method at 15 µg
Lane 2:
Daudi (Human Burkitt's lymphoma lymphoblast) whole cell lysates prepared in 1%SDS Hot lysis method at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 79 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-Bcl6 antibody [EP529Y] (AB33901)
Lanes 1-4 : Merged signal (red and green). Green ab33901 observed at 78 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab33901 Anti-Bcl6 antibody [EP529Y] was shown to react with BCL6 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265410 (knockout cell lysate ab257178) was used. Wild-type and Bcl6 knockout samples were subjected to SDS-PAGE. ab33901 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BCL6 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human BCL6 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-bcl6-knockout-hela-cell-line-ab265410'>ab265410</a>)
Lane 3:
Ramos cell lysate at 20 µg
Lane 4:
SH-SY5Y cell lysate at 20 µg
Predicted band size: 79 kDa
Observed band size: 78 kDa
false
- WB
Unknown
Western blot - Anti-Bcl6 antibody [EP529Y] (AB33901)
Lanes 1-4 : Merged signal (red and green). Green ab33901 observed at 78 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab33901 Anti-Bcl6 antibody [EP529Y] was shown to react with BCL6 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265410 (knockout cell lysate ab257178) was used. Wild-type and Bcl6 knockout samples were subjected to SDS-PAGE. ab33901 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BCL6 knockout HeLa cell lysate at 20 µg
Lane 3:
Ramos cell lysate at 20 µg
Lane 4:
SH-SY5Y cell lysate at 20 µg
Predicted band size: 79 kDa
Observed band size: 78 kDa
false
- WB
Unknown
Western blot - Anti-Bcl6 antibody [EP529Y] (AB33901)
All lanes:
Western blot - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/2000 dilution
All lanes:
Daudi cell lysate
Predicted band size: 79 kDa
Observed band size: 85-90 kDa
false
- WB
Supplier Data
Western blot - Anti-Bcl6 antibody [EP529Y] (AB33901)
Blocking and diluting buffer : 5% NFDM/TBST.
This antibody works better in 1%SDS Hot Lysates in WB. For Lysate preparation protocol, please refer to the protocol section of the website and/or here.
All lanes:
Western blot - Anti-Bcl6 antibody [EP529Y] (ab33901) at 1/1000 dilution
Lane 1:
Daudi (Human Burkitt's lymphoma lymphoblast) whole cell lysates prepared in 1%SDS Hot lysis method at 15 µg
Lane 2:
Ramos (Human Burkitt's lymphoma lymphoblast) whole cell lysates prepared in 1%SDS Hot lysis method at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 79 kDa
false
Exposure time: 10s
Related conjugates and formulations (1)
-
Anti-Bcl6 antibody [EP529Y] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bcl6 plays essential roles in immune response regulation and lymphocyte development. In germinal centers Bcl6 influences the process of somatic hypermutation and class switch recombination in B-cells which is a part of generating antibody diversity. It operates as a central player in a multiprotein complex that includes corepressors such as SMRT and NCoR which facilitate the repression of its target genes. This regulatory action helps maintain the precise balance of immune cell functions.
Pathways
Bcl6 integrates into the B-cell receptor (BCR) signaling and the JAK-STAT pathway. It interacts with molecules like STAT1 and STAT3 positively influencing the survival and proliferation of B-cells. In these pathways Bcl6's activity modulates the transcriptional landscape that determines cell fate decisions affecting cellular processes such as proliferation and survival in response to external cues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
BMC genomics 26:338 PubMed40186114
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1157 PubMed34504602
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neoplasia (New York, N.Y.) 22:142-153 PubMed32062068
2020
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia 33:2867-2883 PubMed31092896
2019
Applications
Unspecified application
Species
Unspecified reactive species
Veterinary pathology 56:350-357 PubMed30636524
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 16:50 PubMed30143009
2018
Applications
Unspecified application
Species
Unspecified reactive species
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 39:1010428317711655 PubMed28671040
2017
Applications
Unspecified application
Species
Unspecified reactive species
Leukemia research 37:21-7 PubMed23026775
2012
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 100:1320-9 PubMed19337254
2009
Applications
WB, IHC-P, ICC/IF
Species
Human, Human, Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com